BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 26, 2002
View Archived Issues
BioCryst Reports Lead Flu Drug Fails In Phase III Against Placebo
BioCryst Pharmaceuticals Inc. stopped development of its lead drug candidate, peramivir, on poor preliminary data from a Phase III influenza study. (BioWorld Today)
Read More
Celera Diagnostics, Abbott Align For In Vitro Molecular Diagnostics
Read More
Key To Hair Loss In Mouse, Man Traced To Key Keratin 17 Mutant Via Two Exotic Follicle Disorders
Read More
Geron Restructuring Leaves Focus On Product Development
Read More
Other News To Note
Read More
Odyssey Raises $15M In Series B To Fund Work In Drug Discovery
Read More